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Introduction
Endochondral ossification is a multistep process in which   
prechondrogenic  mesenchymal  cells  condensate  and  form 
distinct cartilaginous elements. Subsequently, this cartilaginous 
template forms a growth plate necessary for longitudinal growth. 
During development, the growth plate stratifies into zones of 
resting, proliferating, prehypertrophic, and hypertrophic chon-
drocytes, forming a highly interactive structure where each zone 
is influenced by events in the flanking zones and the perichon-
drium (Kronenberg, 2003).
Initiation of chondrogenesis begins with induction of the 
transcription factor Sox9 in limb mesenchyme and subsequent 
condensation of mesenchymal cells (Bi et al., 1999). Next, the 
condensed  cells  differentiate  into  chondrocytes  that,  among 
others, express transcription factors Sox5 and -6 (Smits et al., 
2004) as well as matrix protein collagen type II. As the chon-
droblasts mature, they flatten and align in organized columnar 
structures along the longitudinal axis of the cartilage template, 
forming a transient pool of prehypertrophic cells. Finally, these 
cells exit the cell cycle, enlarge in size, and undergo hyper-
trophy. At this stage, cells in the perichondrium differentiate 
into osteoblasts that deposit an extracellular matrix, which will 
mineralize to form the bone collar. Hypertrophic chondrocytes 
express  collagen  type  X  and  produce VEGF  that  stimulates 
blood  vessel  invasion  in  the  calcified  cartilage  (Provot  and 
Schipani, 2005). Invading osteoclasts will resorb the cartilage 
matrix, and osteoblasts will deposit bone matrix on the cartilage 
remnants (Kronenberg, 2003; Provot and Schipani, 2005).
Several factors regulate the process of endochondral bone 
formation, and one of the more prominent ones is a member   
of the conserved hedgehog (Hh) family of secreted proteins,   
Indian hedgehog (IHH; Bitgood and McMahon, 1995; Vortkamp 
et al., 1996; Hammerschmidt et al., 1997). Hh proteins trans-
duce their signal by binding to a 12-pass transmembrane recep-
tor protein Patched (Ptc). In the absence of Hh, Ptc represses the 
activation of another multipass transmembrane protein, smooth-
ened (smo; Chen and Struhl, 1996; Marigo et al., 1996; Stone   
et al., 1996). Binding of Hh ligands to Ptc relieves the repres-
sion of smo, activating the Hh signal transduction pathway that 
is mediated by Gli transcription factors (Gli1, Gli2, and Gli3). 
Although Gli1 functions as an activator, Gli2 and -3 can act   
either as transcriptional activators or repressors depending on 
the cellular context (Matise and Joyner, 1999; Mullor et al., 2002;   
Cohen, 2003; Nieuwenhuis and Hui, 2005).
I
ndian  hedgehog  (Ihh)  regulates  proliferation  and   
differentiation of chondrocytes in the growth plate. 
Although the biology of Ihh is currently well documented, 
its transcriptional regulation is poorly understood. -EF1 
is a two-handed zinc finger/homeodomain transcriptional 
repressor. Targeted inactivation of mouse -EF1 leads 
to skeletal abnormalities including disorganized growth 
plates, shortening of long bones, and joint fusions, which 
are reminiscent of defects associated with deregulation of 
Ihh signaling. Here, we show that the absence of -EF1 
results in delayed hypertrophic differentiation of chondro-
cytes and increased cell proliferation in the growth plate. 
Further, we demonstrate that -EF1 binds to the putative 
regulatory elements in intron 1 of Ihh in vitro and in vivo, 
resulting in down-regulation of Ihh expression. Finally, we 
show that -EF1 haploinsufficiency leads to a postnatal 
increase in trabecular bone mass associated with en-
hanced Ihh expression. In summary, we have identified   
-EF1 as an in vivo negative regulator of Ihh expression in 
the growth plate.
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et al., 1996; Cabanillas and Darling, 1996). -EF1 binds DNA 
as a monomer to bipartite CACCT(G) sequences separated by 
8–60 nucleotides and located near (±2 kb) the promoter start 
site. -EF1 has been proposed to be a transcriptional repressor–
binding E2 box containing sequences and negatively regulating 
muscle differentiation in vitro (Postigo and Dean, 1997), inte-
grin expression in myoblasts (Jethanandani and Kramer, 2005), 
and vascular smooth muscle cell differentiation (Nishimura   
et al., 2006). Additionally, the repressor function of -EF1 in 
vitro has been shown for Col2a1 promoter activity in chondro-
cytes and for Pro-1-collagen gene expression in osteoblasts 
(Murray et al., 2000; Terraz et al., 2001). -EF1 is expressed in   
the lens, the central nervous system, skeletal precursors, the   
notochord, the myotome, and the limb bud mesenchyme (Takagi   
et al., 1998; Tylzanowski et al., 2003). Postnatally, -EF1 protein   
expression was detected in the growth plate and articular and 
meniscal cartilage of mature mice (Davies et al., 2002).
In the present study, we identified -EF1 as a candidate 
regulator gene of Ihh expression in the growth plate of mice.   
We show that -EF1 binds to the Ihh intron 1 transcription regu-
latory element in vitro and in vivo and that absence of -EF1 
leads to temporal deregulation of Ihh in developing limbs.   
Finally we demonstrate that haploinsufficiency for -EF1 asso-
ciated with enhanced Ihh expression leads to increased bone 
mass in adult mice.
Results
-EF1–null mice exhibit defects in 
hypertrophic differentiation
Detailed description of the developing bones of -EF1
/ mice 
has not been published to date. To better understand the observed 
skeletal phenotype, we performed histological analysis of limbs 
from -EF1–null mice at different stages of development.
At  12.5  days  postcoitum  (dpc),  no  significant  differ-
ences were detected between mutant and wild-type (WT) limbs 
(unpublished data). The first signs of calcification in the WT   
humerus were visible at 13.5 dpc with the formation of a bone 
collar,  whereas  in  -EF1
/  mice,  this  process  was  delayed 
(unpublished data). At 14.5 dpc, limbs of -EF1
/ mice were 
shorter than limbs of WT mice (Fig. 1, A and B). Histological 
analysis revealed that the length of the hypertrophic zone was 
reduced in -EF1
/ mice as compared with WT mice (Fig. 1, 
C and D, compare red and black bars; and Fig. 1, I, J, and K, 
which shows the quantification of the different cartilage zones), 
whereas  the  zones  of  resting  and  proliferating  chondrocytes 
were enlarged (Fig. 1, E, F, and K), but there was no appar-
ent difference in columnar organization (Fig. 1, G and H). At   
16.5 dpc, the delay in hypertrophic differentiation became 
more pronounced (Fig. 1, A–K) and, in addition, we observed   
defects in columnar cell organization with fewer stacks of cells 
(Fig. 1, G and H, arrowheads). This phenotype became more 
pronounced at 18.5 dpc, where a population of enlarged, oval 
chondrocytes  was  present  instead  of  stacks  of  flat-shaped 
chondrocytes (Fig. 1, G and H, arrowheads).
Chondrocyte  hypertrophy  was  further  analyzed  by  in 
situ hybridization with probes for Col2a1 and Col10a1 mRNA 
Ihh is expressed in prehypertrophic and hypertrophic 
chondrocytes  controlling  several  important  differentiation 
steps in the development of the endochondral skeleton. Ihh 
regulates chondrocyte differentiation by activating the ex-
pression  of  parathyroid  hormone–related  protein  (PTHrP; 
Pthlh) in the periarticular cells. PTHrP is a paracrine signal-
ing molecule that diffuses toward the prehypertrophic zone 
and signals through its receptor, PTHrP receptor (PPR), to   
inhibit hypertrophic differentiation, ensuring a supply of pro-
liferating chondrocytes essential for the formation of hyper-
trophic cells and thus longitudinal growth (Vortkamp et al., 
1996; Lanske et al., 1999; Karp et al., 2000). Ihh also regu-
lates  chondrocyte  proliferation  independently  of  PTHrP. 
Analysis of Ihh-null mice expressing a constitutively active 
mutant of PPR showed that the proliferation defect in Ihh-null 
mice was independent of PTHrP signaling (St Jacques et al., 
1999; Karp et al., 2000; Long et al., 2001). Furthermore, Ihh 
also regulates ossification of the perichondrium, where it is 
required for the initial specification of osteoblast progenitor 
cells but not for the formation of mature osteoblasts (Rodda 
and McMahon, 2006). Besides its function in osteo- and chondro-
genic differentiation, Ihh is also involved in the endothelial 
cell fate determination and blood vessel formation because 
Ihh
/ blood vessels do invade the mutant hypertrophic carti-
lage but cannot persist (Colnot et al., 2005).
Even though Ihh is one of the key regulators of endochon-
dral ossification, surprisingly little is known about the mecha-
nisms by which the expression of Ihh is regulated. It has been 
reported that one of the key transcriptional regulators of endo-
chondral bone formation, Runx2, is activating the Ihh promoter 
in vitro (Yoshida et al., 2004). Ihh expression could also be a 
target of Wnt signaling because a direct interaction between the 
Ihh promoter and the -catenin–Lef1 complex in vivo has been 
demonstrated (Später et al., 2006).
A precise regulation of Ihh is important for endochondral 
bone formation, as shown by various skeletal phenotypes in-
duced by modulation of Ihh gene expression. For example, 
Ihh-null mice exhibit short-limb dwarfism with reduced chon-
drocyte proliferation and extensive hypertrophy (St-Jacques   
et al., 1999). Ihh overexpression, however, leads to delayed 
chondrocyte differentiation, delayed ossification of the long 
bones, and expansion of the growth plate with increased pro-
liferation (Vortkamp et al., 1996; Kobayashi et al., 2005).   
Additionally, misexpression of Hh proteins in the cartilage 
leads to joint fusions (Tavella et al., 2004).
Interestingly,  the  described  phenotypes  of  Ihh  over-
expression are very similar to skeletal abnormalities observed   
in -EF1–null mice (Takagi et al., 1998). Targeted inactiva-
tion  of  the  -EF1  gene  leads  to  craniofacial  abnormalities,   
sternum, rib, and limb defects such as shortening and broad-
ening of long bones, and joint and carpal/tarsal bone fusions   
(Takagi et al., 1998).
-EF1 is a two-handed zinc finger transcription factor 
(Funahashi et al., 1993). The gene has been described indepen-
dently as Zfxh1a in mice, ZEB/AREB6/Nil-2-a in humans, BZP 
in hamsters, and Zfhep in rats (Williams et al., 1991; Watanabe 
et al., 1993; Franklin et al., 1994; Genetta et al., 1994; Sekido 687 -EF1 regulates Ihh in the growth plate • Bellon et al.
transduction. We analyzed the mRNA’s expression of Ihh and its 
receptor and target Ptc, as well as PTHrP and PPR. Ihh mRNA 
expression was maintained in the prehypertrophic and hyper-
trophic zones but had a broader expression domain as compared 
with WT littermates (Fig. 2, I and J, compare red and black   
arrows). Ptc mRNA was detected in the perichondrium adjacent 
to the expression domain of Ihh and in the zone of proliferat-
ing chondrocytes. Interestingly, in -EF1
/ mice, the domain 
of Ptc mRNA expression was extended toward the epiphyses 
(Fig. 2, K and L). The expression of PPR was broadened in   
-EF1
/ limbs as compared with WTs (Fig. 2, M and N). 
PTHrP expression was detected in round chondrocytes at the 
ends of long bones of the WT limbs (Hilton et al., 2007), but 
there was a marked increase in PTHrP expression around the 
epiphyses of the long bones of -EF1
/ mice (Fig. 2, O and P, 
(markers  for  nonhypertrophic  and  hypertrophic  chondrocytes, 
respectively).  The  Col2a1  mRNA  expression  domain  was   
considerably longer in -EF1–null mice as compared with 
WT littermates (Fig. 2, A and B, compare red and black lines). 
Conversely, the Col10a1 mRNA expression domain was smaller in   
-EF1
/ mice (Fig. 2, C and D, compare red and black lines), which   
suggests a delay in the onset of hypertrophic differentiation   
in the -EF1–null embryos. The expression domain of Col1a1 
mRNA (an ossification marker) was reduced (Fig. 2, E and F, 
compare red and black lines), and mineralization was delayed as 
visualized by von Kossa staining (Fig. 2, G and H). The osteo-
blast precursors were, however, present in the perichondrium, as 
indicated by alkaline phosphatase staining (unpublished data).
The defects in chondrocyte maturation prompted us to   
examine the expression of genes associated with Ihh signal 
Figure 1.  Analysis of the skeletogenesis in -EF1
/ mice. (A–B) Alizarin red/Alcian blue staining of forelimbs of WT and -EF1
/ mice at 14.5 dpc 
(A and B), 16.5 dpc (A’ and B’), and 18.5 dpc (A’’ and B’’). (C–D’’) Safranin O staining of humerus of WT and -EF1
/ mice at 14.5 dpc (C and D),   
16.5 dpc (C’ and D’), and 18.5 dpc (C’’–D’’). The yellow, blue, and green rectangles correspond to proliferating, prehypertrophic, and hypertrophic 
zones of the growth plate and are magnified in E–J’’. The arrowheads in G’ and H’ indicate perturbed column formation of prehypertrophic chondrocytes 
in -EF1–null mice as compared with WT mice. The brackets in G’’ and H’’ indicate columnar stacks. The black and yellow lines in I’–J’’ indicate the size of 
the hypertrophic zone in WT and -EF1–null mice, respectively. Note the disturbed columnar organization as well as the reduced size of prehypertrophic 
and hypertrophic zones in -EF1–null mice. (K–K’’) Measurements of the different cartilage zones in WT (black) and -EF1–null mice (gray; n = 4 embryos, 
5 measurements per embryo in each group; error bars indicate mean ± SD, student’s t test; *, P < 0.0001). Bars: (A–D’’) 500 µm; (E–J’’) 100 µm.JCB • VOLUME 187 • NUMBER 5 • 2009   688
the proliferative zone (both in noncolumnar and columnar cells)   
of -EF1
/ mice as compared with WT littermates (Fig. 4, A–B) 
at 16.5 dpc. The number of proliferating cells in the humerus 
of the mutant was 50% higher than in WT mice (Fig. 4 C).   
Thus, in the absence of -EF1, the balance between prolifera-
tion and differentiation of chondrocytes was changed with a 
higher rate of chondrocyte proliferation.
Ihh expression is affected in -EF1 mutants
Having demonstrated that -EF1–null mice show an increased 
cell proliferation in the growth plate, we decided to analyze 
the expression of Ihh during chondrogenesis in detail. In WT 
mice at 15.5 dpc, IHH protein was detected in prehypertrophic 
and  hypertrophic  chondrocytes,  and  no  IHH-positive  cells 
were  detected  in  the  domains  of  resting  and  proliferating 
chondrocytes  (Fig.  5, A  and A;  Koziel  et  al.,  2004).  In   
-EF1
/ mice, however, a significant amount of IHH-positive 
cells  was  detected  in  the  proliferating  region  of  -EF1
/ 
mice, and IHH-positive cells were detected in the entire growth 
plate (Fig. 5, B and B). Similar results were obtained at 14.5 
and 16.5 dpc (unpublished data). To analyze the dynamics of 
IHH and -EF1 protein expression during limb development, 
we performed Western blot analysis (Fig. 5 C). -EF1 was   
detected from 12.5 dpc, with the expression peak at 14.5 dpc. 
From 16.5 dpc, -EF1 expression could no longer be detected. 
IHH protein expression was detected from 12.5 dpc onwards, 
and the expression increased over time. IHH expression in   
-EF1
/ limbs was higher as compared with the correspond-
ing stages of WT limbs (Fig. 5 C, * and ^), confirming the 
immunohistochemistry  data.  Quantification  of  the  Western 
blot bands showed a twofold increase in Ihh expression in   
-EF1
/ limbs at 13.5 dpc as compared with WT, and a 1.5-
fold increase at 18.5 dpc (Fig. 5 C).
arrows). The changes in the expression pattern of the above-
mentioned molecular markers were the same in all long bones 
examined (unpublished data). In summary, -EF1 deficiency 
resulted in a delay of chondrocyte hypertrophic differentiation.
-EF1 expression in the growth plate
Because -EF1–null mice have apparent defects in the growth 
plates of the long bones, we decided to reexamine -EF1 tran-
scripts  during  bone  development.  Previous  studies  showed   
-EF1 mRNA expressed in the perichondrium of long bones at 
14.5 dpc (Takagi et al., 1998; Tylzanowski et al., 2003). Our 
analysis has revealed additional expression domains of -EF1 
mRNA in the growth plate on sections of 14.5 dpc (Fig. 3) and 
16.5 dpc (not depicted) mouse embryos using two independent 
in situ hybridization methods: colorimetric (Fig. 3, A and B) 
and fluorescent (Fig. 3, C and D). -EF1 transcripts were   
detected in the entire growth plate (Fig. 3, A and C, red arrows) 
as well as in some muscles (Fig. 3 A, black arrow; and Fig. 3 C, 
white arrow; Funahashi et al., 1993). We did not detect expres-
sion of -EF1 mRNA in limbs of -EF1
/ mice (Fig. 3, B and D). 
The expression of -EF1 mRNA became weaker toward the 
zone of hypertrophic chondrocytes (Fig. 3 A). These findings 
indicate that -EF1 mRNA is located at the appropriate place 
and time during bone development in mice to regulate growth 
plate differentiation.
Increased chondrocyte proliferation  
in -EF1
/ cartilage
-EF1
/ mice display an enlarged zone of resting and pro-
liferating chondrocytes. Because this could have been caused   
by enhanced proliferation, we analyzed the expression of Ki67, 
an acknowledged molecular marker of that process. There was   
a significant increase in the number of cells positive for Ki67 in 
Figure 2.  Hypertrophic differentiation is delayed in -EF1 KO mice. (A–F and I–P) In situ hybridization for different growth plate markers (named to the left) 
on the radius and ulna of 14.5-dpc (O and P) and 16.5-dpc (A–N) WT and -EF1 KO limbs. (A and B) The zone of Col2a1 mRNA expression is expanded 
in -EF1
/ mice as compared with WT (black line, WT; red line, -EF1 KO throughout this figure). (C and D) The region of Col10a1 mRNA–expressing 
cells is reduced in -EF1
/ mice. (E and F). Col1a1 mRNA expression is reduced in -EF1
/ mice. (G and H) Von Kossa staining of WT (G) and -EF1
/ 
limbs (H) showing a delay in bone mineralization in -EF1
/ mice. (I and J) The domain of Ihh mRNA expression is broadened. (K and L) The domain of Ptc 
mRNA expression is expanded in -EF1
/ limbs as compared with WT limbs. (M and N) PPR mRNA expression is broader in -EF1 KO mice as compared 
with WT mice (O and P). PTHrP mRNA expression on 14.5-dpc forelimbs is increased in -EF1
/ limbs as compared with WT limbs (arrows).689 -EF1 regulates Ihh in the growth plate • Bellon et al.
limbs (Fig. 5 E), which supports the notion that the increase in 
Ihh transcription may have biological consequences in vivo.
Ihh has both PTHrP-dependent and independent effects 
on growth plate development. To determine if the defects 
seen in the growth plates of -EF1–null mice were PTHrP 
mediated,  we  analyzed  the  expression  of  PTHrP  mRNA. 
Similar to Ihh and Ptc, the mRNA expression of PTHrP was 
increased in -EF1
/ limbs at all stages (Fig. 5 F) as com-
pared with WT controls.
Because there was a limited expansion of the Ihh mRNA 
expression domain (as shown in Fig. 2), we measured Ihh 
mRNA  expression  by  quantitative  PCR.  Ihh  mRNA  expres-
sion in the developing limbs was increased in -EF1
/ mice 
at all stages from 12.5 dpc onwards, with a peak at 14.5 dpc   
(Fig. 5 D). These results show that even though the expression 
domain of Ihh mRNA was only slightly expanded, transcrip-
tion levels of Ihh were increased. Importantly, a similar increase 
in expression of Ihh target gene Ptc was detected in -EF1
/ 
Figure  3.  -EF1  mRNA  expression.  In  situ 
hybridization (A and B, colorimetric-positive 
signal  blue;  C  and  D,  fluorescent-positive 
signal red) for -EF1 on longitudinal sections 
of  14.5-dpc  WT  (A  and  C)  and  -EF1  KO 
limbs (B and D). -EF1 mRNA is expressed in 
WT limbs in the growth plate (red arrows in   
A and C) and certain muscles (black and white   
arrows in A and C). No -EF1 mRNA expression 
could be detected in -EF1 KO limbs (B and D).   
Bars, 100 µm.
Figure  4.  Increased  proliferation  in  the 
growth plate of -EF1–null mice. Immunohisto-
chemistry for Ki67 in the humerus of WT (A) 
and -EF1–null mice (B) at 16.5 dpc. The black 
rectangle denotes the area magnified in the 
insets. (C) There are more proliferating cells in 
-EF1 KO mice as compared with WT (n = 20; 
the y axis shows the percentage of Ki67-positive 
cells compared with the total cell number in 
selected area; bars indicate ±SD, Student’s   
t test; *, P < 0.00001).JCB • VOLUME 187 • NUMBER 5 • 2009   690
is their evolutionary conservation across species. Therefore, we 
aligned the genomic sequence of the mouse Ihh to rat, human, 
dog, cow, chimp, and chicken Ihh sequences using VISTA soft-
ware (Dubchak et al., 2000; Frazer et al., 2004). We found that 
the 160-bp region in the Ihh gene containing putative -EF1 
binding sites was highly conserved across species (Fig. 6 B, 
black box).
Next, we investigated if -EF1 could bind to these sequences 
in vitro carrying out electrophoretic mobility shift assay (EMSA) 
using amino-terminally tagged myc–-EF1 and a 65-bp frag-
ment of the mouse Ihh intron 1 containing CACCT/CACCTG 
In conclusion, deficiency of -EF1 leads to higher levels 
of Ihh mRNA expression and increased IHH protein levels.
-EF1 binds in vitro and in vivo to Ihh
Because the -EF1–null phenotype in mice was reminiscent of 
phenotypes associated with perturbed IHH signaling, we investigated 
if -EF1 could bind directly to regulatory regions of the Ihh gene. 
Indeed, we found four putative -EF1 binding sites in a region of   
160 bp at the 5 end of intron 1 of the mouse Ihh gene (Fig. 6 A).
One of the indications of a potential functional signifi-
cance of DNA sequences located in noncoding regions of DNA 
Figure 5.  Ihh expression in -EF1–null mice. (A–B) Immunohistochemistry for Ihh shows the presence of IHH in the resting and proliferating regions of   
-EF1
/ mice (magnified view in A’ and B’, indicated by black boxes in A and B). (C) Western blot analysis for IHH, -EF1, and glyceraldehyde   
3-phosphate dehydrogenase (GAPDH) on limb extracts of different stages of WT (left) and -EF1
/ (right) mice. * and ^ indicate the IHH expression at 
13.5 and 18.5 dpc, respectively; quantification of these Western blot bands by densitometry analysis is shown in C’. (D–F) Quantitative PCR for Ihh, Ptc, and 
PTHrP on limb lysates of different stages of embryonic development of WT (gray) and -EF1 KO mice (black). Each bar represents a pool of 10 limbs. 
Samples were normalized to the geometric mean of three housekeeping genes (GAPDH, Hprt1, and 2-microglobulin). Bars represent levels (±SD) of 
expression relative to WT 11.5 dpc.691 -EF1 regulates Ihh in the growth plate • Bellon et al.
is dependent on the presence of an intact bipartite CACCT/
CACCTG binding site.
Although EMSA provides the information about the abil-
ity of a transcription factor to bind to its target sequence, it does 
not indicate if such a binding takes place in vivo and is therefore 
biologically relevant. To address this issue, we have performed 
chromatin immunoprecipitation (ChIP) experiments. We have 
designed PCR primers encompassing the 160-bp region con-
taining -EF1 putative binding sites in the Ihh intron 1 and per-
formed ChIP analysis on 16.5-dpc mouse embryos. After protein 
cross-linking to DNA, we performed immunoprecipitation   
using -EF1–specific antibodies (ZEB; Eger et al., 2005). As 
can be seen in Fig. 6 E, we were able to amplify the Ihh  
intron 1 fragment in the DNA templates obtained after immuno-
precipitation with anti--EF1 (ZEB) antibodies but not from the 
IgG controls. Importantly, we did not detect any PCR product in 
sites as a probe (see Fig. 6 C and Materials and methods).   
We could demonstrate that myc–-EF1 could bind to the intron 1 
fragment of Ihh (Fig. 6 D). Next, we confirmed the specificity 
of myc–-EF1 binding by carrying out a supershift of the   
-EF1 band with a monoclonal anti-myc antibody (Fig. 6 D, 
lanes 2 and 3). To verify that the binding was dependent on the 
presence of the intact bipartite CACCT…CACCTG motif, we 
performed competition assays. As can be seen on Fig. 6 D 
(lane 4), the WT Ihh fragment competed for -EF1 binding 
with 20-fold the molar excess of the WT, unlabeled, probe. 
The CATCT…CATCTG mutant (CACCT(G) binding sites are 
underlined, point mutations in mutated constructs are shown 
in bold; Fig. 6 D, lane 5) was unable to compete for binding 
to -EF1.
Collectively, the results in Fig. 6 C show that -EF1 can 
bind to the Ihh intron 1 fragment in vitro and that this binding   
Figure 6.  -EF1 binds to the Ihh intron 1 regulatory region in vitro and in vivo. (A) Schematic representation of the Exon 1/Intron 1 junction of the Ihh 
gene. Exon 1 is indicated by a gray arrow (752 bp). Four CACCT(G) putative binding sites in the 5 end of intron 1 are indicated. The green line and red 
dotted line in A, B, and C correspond to exon 1 (green line) and intron 1 (red dotted line). (B) Alignment of the genomic DNA of Ihh for different species 
(mouse compared with 1, rat; 2, human; 3, dog; 4, cow; 5, chimp; and 6, chicken). The region in the black rectangle corresponds to the region with the 
CACCT(G) binding sites and is strongly conserved across species (gray peaks). (C) A sequence alignment of exon 1/intron 1 junction. CACCT(G) binding 
sites are indicated in yellow. The chick sequence with binding sites indicated is located below the exon 1/intron 1 schematic drawing. Black background 
and white letters indicate 100% identity, gray background and white letters indicate >80% identity. The fragment of 65 bp used for EMSA is indicated with 
a red rectangle. Numbers indicate position on the chromosome. (D) EMSA for binding of -EF1 to a selected region of the Ihh intron 1 regulatory region 
of 65 bp (indicated in red in C; the primer sequence to generate the fragment is described in Materials and methods). In each lane, a -
32P-labeled probe 
was added to extract of cells transfected with GFP (lane 1) or -EF1 (lanes 2, 3, 4, and 5). Lane 3, supershift after adding -EF1 monoclonal anti-Myc 
antibody; lane 4, competition with a 20-fold unlabeled probe; lane 5, no competition with 20-fold unlabeled probe with mutant CACCT(G) binding sites: 
CATCT(G). Arrows indicate shift (lane 2) and supershift (lane 3). (E) ChIP assay for in vivo binding of -EF1 to Ihh done on lysates from WT and -EF1 KO 
limbs. Lane 1, molecular weight marker; lane 2, input DNA; lane 3, IgG negative control on WT cell lysates; lane 4, IgG negative control on -EF1
/  
lysates; lane 5, ChIP assay using -EF1–specific antibodies (ZEB) on WT cell lysate; lane 6, ChIP assay using -EF1–specific antibodies (ZEB) on -EF1
/ 
cell lysate; lane 7 and 8, positive (genomic DNA) and negative (water) PCR control, respectively. (top) Detection of a fragment of the Ihh regulatory region of   
211 bp containing the selected region by PCR with specific primers (lane 5). (middle and bottom) Control PCRs for unrelated genomic sequences (Noggin 
and Sip1, respectively) to demonstrate specificity of -EF1 binding to the Ihh first intron. No Ihh fragment was detected after precipitation using -EF1–specific 
antibodies (ZEB; lane 5).JCB • VOLUME 187 • NUMBER 5 • 2009   692
Figure 7.  -EF1 negatively regulates Ihh expression. (A–A’) Misexpression of -EF1 in developing chick limbs. Skeletal stainings of chick limbs HH 
stage 37 electroporated with chick -EF1 cDNA (A’) as compared with the contralateral limb (A). The length of the long bones of limbs electroporated with   
-EF1 cDNA is shorter as the contralateral limbs (compare the red bar in A’ with the black bar in A and A’). (B and B’) Safranin O staining at HH stage 37 of 693 -EF1 regulates Ihh in the growth plate • Bellon et al.
the lysate obtained from -EF1–null mice. As seen in the lower 
panels of Fig. 6 E, we did not detect the presence of unrelated 
genomic sequences (noggin and Sip1), which ruled out the pos-
sibility that the chromatin containing Ihh intron 1 was pulled 
down nonspecifically with -EF1 containing chromatin. These 
results strongly support the notion that intact -EF1 binds in 
vivo to cognate target sequences present in intron 1 of Ihh.
Misexpression of -EF1 in developing chick 
limbs results in growth plate defects and 
decreased IHH signaling
We demonstrated that binding of -EF1 to Ihh intron 1 takes 
place both in vitro and in vivo; however, whether this binding 
would  repress  or  activate  gene  transcription  remained  unre-
solved. Therefore, we performed gain-of-function experiments 
by misexpressing myc–-EF1 cDNA in developing chick limbs. 
Chick limbs of Hamburger-Hamilton (HH) stage 18–20 were 
electroporated with myc–-EF1 in a pCS3 expression construct 
and incubated until HH stage 36–37, when a skeletal staining 
was  performed.  Limbs  electroporated  with  -EF1  construct 
were reduced in size as compared with the contralateral control 
limbs  or  limbs  electroporated  with  empty  expression  vector 
(Fig. 7, A and A; and not depicted). The length of the long 
bones was reduced by a mean of 25% in the zeugopod and by a 
mean of 40% in the stylopod, as compared with control limbs 
electroporated  with  pCS3  alone  at  the  same  developmental 
stage. Additionally, in some limbs, a small reduction in length 
of the autopod was detected (unpublished data).
To evaluate if the -EF1 cDNA was successfully ex-
pressed in the chick limb, we performed a Western blot analysis 
on protein samples obtained from electroporated chick limbs 
using anti-myc primary antibody. Western blot analysis of the 
cell lysate of transfected limbs, as well as DF1 cells transfected 
with the same expression construct, revealed a band of 140 kD. 
Importantly, we could detect -EF1 in the cell lysates from 
limbs that did show the phenotype but could not detect it in the 
limbs electroporated with -EF1 expression construct but not 
having the above described phenotype (Fig. 7 D), which sup-
ports the notion that the observed phenotype was directly corre-
lated with the successful expression of -EF1.
Histologically, the limbs electroporated with -EF1 cDNA 
showed  a  significant  reduction  of  the  zone  of  hypertrophic 
chondrocytes, and bone formation was delayed (Fig. 7, A, A, 
B, and B). Furthermore, the distance between the epiphysis and 
the zone of hypertrophic chondrocytes, as indicated by Col10a1 
mRNA  expression,  is  enlarged  in  limbs  electroporated  with   
-EF1 cDNA (Fig. 7, C and C). These observations suggested 
a delayed onset of hypertrophic and osteogenic differentiation 
and therefore a possible defect in Ihh signaling induced by mis-
expression of -EF1. To investigate this hypothesis, we per-
formed  quantitative  PCR  to  measure  Ihh  expression  levels. 
Limbs electroporated with -EF1 cDNA showed a significant 
reduction in Ihh expression (Fig. 7 E). To analyze the specificity 
of this repression, we tested the expression of Col2a1, which is 
negatively regulated by -EF1 in vitro (Murray et al., 2000). 
Col2a1 mRNA expression was unchanged in -EF1 electro-
porated limbs as compared with control limbs (Fig. 7 E). There-
fore, in spite of -EF1 overexpression in the entire limb bud of 
developing chicks, the in vivo repressor effect of -EF1 was 
specific, affecting Ihh expression in the growth plate but not   
another in vitro identified target gene Col2a1. These results were 
confirmed using dual in situ hybridization for Col2a1 and Ihh. 
Limbs electroporated with -EF1 cDNA showed a significant 
reduction in Ihh mRNA expression (Fig. 7 F, red), whereas   
expression of Col2a1 mRNA was unchanged (Fig. 7 F, green). 
The overexpression of -EF1 cDNA in developing chick limbs 
provides strong evidence for a role of -EF1 as negative regula-
tor of Ihh in the growth plate. To further confirm that -EF1 
negatively regulates expression of the Ihh gene, we tested 
whether -EF1 interacts in the transcriptional control of Ihh  
expression. We therefore cotransfected reporter plasmids con-
taining the Ihh intron 1 regulatory region with a -EF1 expres-
sion plasmid. Overexpression of -EF1 in both C17 mouse limb 
bud cells and DF1 chicken fibroblasts consistently inhibited the 
activity of the Ihh intron 1 reporter construct (Fig.7, G and H).   
-EF1 could not, however, inhibit the activity of the construct 
with mutated CACCT(G) binding sites, which indicates that the 
intact  CACCT(G)  -EF1  binding  sites  are  required  for  this   
activity (Fig. 7, G and H).
-EF1 haploinsufficiency causes a postnatal 
increase in trabecular bone mass
We have demonstrated that the skeletal phenotype of -EF1
/ 
embryos was caused by a disturbed Ihh signaling. Several studies 
implicate Ihh in postnatal bone homeostasis (Maeda et al., 2007; 
Mak et al., 2008; Ohba et al., 2008). Therefore, we investigated 
if deficiency of -EF1 would lead to a postnatal bone pheno-
type. Because homozygous mutants die at birth, we analyzed   
20-wk-old -EF1 heterozygous (HZ) mice. The radiographical 
analysis revealed normal skeletal patterning in -EF1
+/ mice   
tibia of chicken electroporated with chick -EF1 cDNA. P, proliferating; C, prehypertrophic; H, hypertrophic chondrocytes; T, total length of the growth 
plate. (C and C’) In situ hybridization for cCol10a1 at HH39 on tibia of chicks electroporated with chick -EF1 cDNA and control limbs. The black and 
red lines indicate the distance from the epiphysis to the zone of hypertrophic chondrocytes in the control limbs and limbs electroporated with -EF1 cDNA, 
respectively. (D) Western blot analysis of the lysate of electroporated limbs with anti-myc antibody. Lane 1, representation of molecular weight marker; 
lane 2, lysate obtained from DF1 chick cell fibroblasts transfected with chick -EF1 cDNA; lane 3, lysate of limbs electroporated with -EF1 cDNA showing 
a phenotype; lane 4, lysate of limbs electroporated with -EF1 cDNA not showing a phenotype; lane 5, lysate of limbs electroporated with GFP cDNA. The 
arrow indicates the position of the positive band on the gel. (E) Quantitative PCR analysis of electroporated limbs shows a down-regulation of Ihh mRNA 
in limbs electroporated with -EF1 cDNA, whereas Col2a1 mRNA expression was unchanged (n = 6, Student’s t test; *, P < 0.00001; relative expression 
is normalized to -actin). (F) Dual in situ hybridization for Col2a1 (green) and Ihh (red). Chick limbs of HH30 electroporated with -EF1 show a decreased 
Ihh expression as compared with contralateral control limbs. (G and H) Effects of -EF1 on the transcriptional activity of Ihh intron 1 construct. Luciferase 
reporter constructs containing WT or mutated -EF1 binding sites from Ihh intron 1 were cotransfected into cultured C17 (C) or DF1 (D) cells with either 
a -EF1 expression vector or empty vector in different concentrations (indicated below the graph). Bars in the graphs indicate relative luciferase activity 
normalized to -galactosidase activity, presented as mean ± SD, n = 3. Bars: (A–C’) 1 mm; F, 100 µm.
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increase in the size of the domain of proliferating chondro-
cytes and their proliferation rate. Both these defects are con-
sistent with the growth plate phenotypes observed in Ihh-null 
mice (St-Jacques et al., 1999). Conversely, a misexpression of 
Ihh under control of Collagen type 2 promoter induced Ptc 
mRNA and delayed Col10a1 mRNA expression (Long et al., 
2004). These observations are very similar to our findings in 
-EF1–null mice, which suggests a link between -EF1 and 
Ihh signaling.
Ihh  directly  induces  proliferation  of  prehypertrophic 
chondrocytes (Long et al., 2001). Targeted inactivation of -EF1 
leads to significant increase in the proliferation of chondrocytes. 
Conversely, overexpression of -EF1 in the developing chick   
limb leads to reduced length of the zone of proliferating chon-
drocytes. This effect would be expected if the expression lev-
els of Ihh would be changed, indicating that the growth plate   
defects observed in -EF1
/ mice are consistent with the   
phenotypes observed after deregulation of Ihh expression. Next 
to the direct effect of Ihh on chondrocyte proliferation, Ihh 
also has PTHrP-dependent effects on chondrocyte differentia-
tion. Ihh induces the expression of PTHrP in the periarticular 
perichondrium, which will block hypertrophic differentiation 
(Vortkamp et al., 1996; Karp et al., 2000). The increase in Ihh 
gene expression in -EF1–null mice leads to increased PTHrP 
expression in the periarticular perichondrium. This augmented 
PTHrP  expression  is  likely  to  cause  the  observed  delay  in   
hypertrophic  differentiation  in  -EF1–null  mice.  In  support 
of our hypothesis, it was recently shown that PTHrP signal-
ing activity is negatively regulated by Wnt/-catenin signaling 
to initiate chondrocyte hypertrophy (Guo et al., 2009). In this 
case, the up-regulation of PTHrP in -EF1–null mice could 
be partially counteracted by Wnt/-catenin signaling, and this 
could explain a rather mild phenotype of -EF1–null mice. 
Furthermore, final maturation of chondrocytes in -EF1–null 
mice appears to be less affected, as seen by Col10a1 mRNA 
expression. Our data suggest that terminal chondrocyte differ-
entiation is a separate event that is still intact in -EF1–null 
mice. This is further supported by the observation that Wnt/ 
-catenin signaling controls final maturation of chondrocytes   
independently of PTHrP (Guo et al., 2009).
(unpublished  data).  Next,  we  performed  whole-body  dual   
energy x-ray absorptiometry (DEXA) measurements of muscle, 
bone, and fat content. This analysis revealed a significant in-
crease in bone mineral density and bone mineral content as com-
pared with WT mice (Table I), and no difference in muscle and 
fat mass. Peripheral quantitative computed tomography (pQCT) 
analysis detected a significant increase in the bone trabecular 
content  and  trabecular  density  in  -EF1
+/  mice  (Table  II).   
To analyze if these observations could be associated with a 
change in Ihh expression, we performed quantitative PCR on 
dissected growth plates of 8-wk-old WT and -EF1 HZ mice. 
Ihh mRNA expression was significantly up-regulated in growth 
plates of -EF1 heterozygotes as compared with WTs (Fig. 8). 
Collectively, haploinsufficiency for -EF1 causes up-regulation 
of Ihh in adult growth plates, a higher bone mineral density, and 
an increase in trabecular bone content.
Discussion
-EF1–null mice have defects in the growth 
plate of the long bones
-EF1–null mice exhibit dwarfism and impaired joint forma-
tion (Takagi et al., 1998), but no detailed histological analysis 
of the developing long bones was available. Therefore, after the 
breeding of mice into a CD1 background, we have reanalyzed 
the reported phenotype with specific focus on the histology of 
the growth plate. Despite the delay in expression of Col10a1, a 
marker gene for hypertrophic differentiation, we still observed 
hypertrophic chondrocytes in the growth plate of -EF1
/ 
mice, which indicates that the hypertrophic differentiation   
was delayed rather than impaired. Additionally, there was an 
Table I.  DEXA analysis of WT and -EF1
+/ mice
Parameter WT -EF1 HZ
DEXA_total BMD (mg/cm²) 0.063 ± 0.004 0.068 ± 0.003
a
DEXA_total BMC (g) 0.674 ± 0.085 0.764 ± 0.039
a
DEXA_total area (cm²) 10.554 ± 0.859 11.221 ± 0.505
DEXA_lean (g) 38.758 ± 3.700 40.940 ± 2.978
DEXA_fat (g) 15.531 ± 2.718 15.623 ± 4.414
DEXA of WT and -EF1
+/ (HZ) mice. n = 8 animals/group; data presented as   
mean ± SD; Student’s t test. BMC, bone mineral content; BMD, bone mineral density.
ap < 0.05.
Table II.  pQCT analysis of WT and -EF1
+/ mice
Parameter WT -EF1 HZ
pQCT_trab content (mg) 0.34 ± 0.08 0.41 ± 0.05
a
pQCT_trab density (mg/cm³) 211.21 ± 34.64 243.61 ± 36.28
a
pQCT_trab area (mm²) 1.61 ± 0.15 1.68 ± 0.13
pQCT_cort content (mg) 2.11 ± 0.40 2.13 ± 0.27
pQCT_cort density (mg/cm³) 1,195.90 ± 64.46 1,197.31 ± 62.44
pQCT_cort area (mm²) 1.77 ± 0.31 1.78 ± 0.21
pQCT_cort thickness (mm) 0.31 ± 0.05 0.31 ± 0.03
pQCT of HZ and WT mice. n = 8 animals/group; data presented as mean ± SD; 
Student’s t test. cort, cortical; tot, total; Trab, trabecular.
ap < 0.05.
Figure 8.  Haploinsufficiency for -EF1 leads to increased Ihh mRNA ex-
pression. Quantitative PCR for Ihh on dissected growth plates of 8-wk-old 
-EF1 HZ mice and WT littermates (n = 6 mice per group, Student’s t test; 
*, P < 0.01; relative expression normalized to -actin).695 -EF1 regulates Ihh in the growth plate • Bellon et al.
Misexpression of -EF1 in the developing 
chick limb results in the delay in growth 
plate maturation
To analyze the effect of -EF1 on the transcription of Ihh,   
we have performed luciferase reporter analyses with the Ihh 
regulatory element constructs and a -EF1 expression plas-
mid. We have shown in two different cell lines that -EF1 has 
a negative regulatory effect on Ihh transcription. The binding 
sites for -EF1 in the first intron are required for this regula-
tion because a point mutation in the CACCT(G) binding sites 
prevents this inhibitory effect of -EF1 on the Ihh transcrip-
tion. These in vitro experiments clearly indicate that -EF1 is 
a negative regulator of Ihh in the growth plate; however, this 
does not necessarily reflect the in vivo situation. Therefore, in 
addition to these in vitro experiments, we performed in vivo 
overexpression of -EF1 to analyze the regulatory function of 
-EF1 specifically in the growth plate. The developing chick 
embryo is a versatile and robust model system to study, among 
other things, limb development and osteochondrogenic differ-
entiation  (Tickle,  2004).  Therefore,  we  have  misexpressed   
-EF1  cDNA  in  developing  chick  limbs  to  investigate  the   
effect on Ihh mRNA expression. Indeed, we achieved a reduc-
tion in Ihh expression in developing chick limbs, which sup-
ports the notion that -EF1 can repress the expression of Ihh 
in vivo. Moreover, we did not detect changes in expression of 
Col2a1, whereas -EF1 has been shown to repress Col2a1 
transcription in vitro (Murray et al., 2000). Although over-
expression experiments have their limitations, the target gene–
specific response in this case is supportive of our hypothesis 
that -EF1 is repressing Ihh transcription in vivo. In chick 
limbs electroporated with -EF1 cDNA, we observed a reduc-
tion in length of the long bones consistent with the Ihh knock-
out (KO) phenotype (St Jacques et al., 1999). Ihh KO mice 
display a dynamic bone phenotype. At 16.5 dpc, they have a 
delay in calcification, but at 18.5 dpc, this process is enhanced 
as compared with the WT littermates. The stage at which we 
analyzed the chick embryos corresponds to the 16.5-dpc stage 
in the Ihh mouse mutants, and the observed delay in calcifica-
tion is consistent with the mouse phenotype. Additionally, it 
was demonstrated that infection of developing chick limb bud 
with Nkx3.2 results in down-regulation of Ihh expression, and 
the bone phenotype is very similar to the one induced by   
-EF1 cDNA (Provot et al., 2006). Namely, there is restriction 
of the Col10a1 expression domain and a delay in hypertrophy. 
Therefore it is likely that there are aspects of growth plate   
biology in the chick that are somewhat different than in the 
mouse. The reason why the induced phenotype is not as pro-
nounced as in the Ihh-null mice is most likely caused by the 
delivery method of -EF1 cDNA. Chick limb electroporation 
delivers DNA to target tissues with variable efficiency, and   
although our system has been optimized for high efficiency 
using GFP expressing vectors, it is unlikely that we are able to 
target all the cells in the developing limb. Consequently, some 
cells  will  escape  -EF1  repression,  causing  a  milder  limb 
phenotype. Another way of misexpressing genes in develop-
ing chick is by using RCAS virus-based system. Although the 
system is very efficient and effective, it has a major limitation 
-EF1 negatively regulates Ihh expression  
in the growth plate
Next, we investigated if the observed phenotypes correlated 
with the changes in Ihh gene expression. Both Ihh mRNA ex-
pression and IHH protein levels were increased in -EF1
/ 
mice. These data support our hypothesis that -EF1 acts as   
a negative regulator of Ihh transcription in the developing 
growth plate.
IHH is a long-range signaling molecule and its move-
ment in the growth plate is dependent on heparan sulfate pro-
teoglycans.  In  mice  deficient  for  glycosyltransferase  Ext1, 
heparan sulfate synthesis is impaired, resulting in an extended 
range of Ihh signaling, as indicated by changes in the expres-
sion levels and/or domains of PTHrP and Ptc mRNAs (Koziel 
et al., 2004). Ext1-null mice have shorter limbs, with joint   
fusions and defects in hypertrophic differentiation similar to 
those detected in -EF1
/ mice. We therefore hypothesize 
that the excess of IHH protein cannot be sequestered by hepa-
ran sulfate, the negative regulator of IHH diffusion. This in 
turn leads to the extended range of IHH signaling in -EF1
/ 
mice and, therefore, phenotypes similar to Ext1 deficiency,   
including the changes in PTHrP and Ptc mRNA expression 
(Koziel et al., 2004).
-EF1 binds to the intron 1 regulatory 
element of Ihh in vitro and in vivo
In several genes, intron 1 has been associated with the pres-
ence of regulatory elements (Reid et al., 1990; Smith et al., 
1996; Antoine and Kiefer, 1998). The Ihh gene contains four 
putative CACCT(G) -EF1 binding sites in a very strongly 
conserved region of intron 1. Our studies demonstrate that   
-EF1 binds to those sequences in vitro and in vivo. The 
ZFHX1 family of transcription factors is known to be involved 
in the repression of gene transcription (Funahashi et al., 1993; 
Kamachi and Kondoh, 1993; Sekido et al., 1994, 1997; Remacle 
et al., 1999; Comijn et al., 2001; Papin et al., 2002). Binding 
of -EF1 to its target sites in vitro has been demonstrated for 
several genes (Murray et al., 2000; Terraz et al., 2001; Eger   
et al., 2005; Jethanandani and Kramer, 2005; Nishimura et al., 
2006), and in all these cases, -EF1 displayed repressor activ-
ity with two exceptions. In one case, -EF1 induced ovalbu-
min expression in estrogen signaling cascades in vitro (Dillner 
and Sanders, 2004). In the other case, -EF1 transactivated 
promoters of smooth muscle cell differentiation marker genes 
in vivo (Nishimura et al., 2006).
Here,  we  demonstrate  that  -EF1  binds  to  its  target   
sequences in the intron 1 regulatory element of Ihh in vivo, 
implying that it could be involved in transcriptional regulation 
of Ihh. This is a novel and important finding because little is 
known about the transcriptional regulation of Ihh expression. 
So far, two genes have been reported to directly interact with the 
Ihh promoter in vivo: Runx2 and Lef1 (Yoshida et al., 2004; 
Später et al., 2006). Both of them act as transcriptional activa-
tors of Ihh, and the identification of a potential in vivo repressor 
of Ihh adds to our understanding of the complex regulatory   
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-EF1  S  as  described  before  and  -EF1  AS  (5-AACCGTGCATCTGC-
CAGTTTGAG-3), generating a fragment of 537 bp.
Immunofluorescence and in situ hybridization
Immunofluorescence was performed using standard protocols using the fol-
lowing primary antibodies: mouse IgG (Biognost), ZEB for detection of   
-EF1 (E-20), IHH (C-15; both from Santa Cruz Biotechnology, Inc.), and 
TEC-3 for detection of Ki67 (Dako). For analysis of cell proliferation, the   
ratio of positive cells to the total cell number in a microscopic field was 
counted (n = 20, with n equal to number of sections; five different em-
bryos). The microscopic field was determined using histological landmarks 
on a photograph. Subsequent analysis was performed on the photographs. 
Statistical analysis was performed using an unpaired student’s t test.
In situ hybridization was performed on paraffin sections using stan-
dard procedures. The mRNA probes (see the Results section) were used as 
described previously (Koziel et al., 2004; Smits et al., 2004; Später et al., 
2006). The -EF1 probe was designed using primers CD183-AS (5-CATAT-
GCTAAATCCGCTTCAG-3)  and  CD184-S  (5-GGTCTTGCTTAAGGC-
CAAAGG-3;  sequence  from  nucleotide  position  3,751–4,160  from 
GenBank/EMBL/DDBJ under accession no. D76432).
Probes were provided by Christine Hartmann (The Research Institute 
of Molecular Pathology, Vienna, Austria), Patrick Smits (Harvard Univer-
sity, Boston, MA), Christa Maas (University of Leuven, Leuven, Belgium), 
and Laetitia Buelens (University of Essen, Essen, Germany).
In ovo electroporation
Fertilized eggs (Poel-Houben) were incubated at 38.5°C in a humidified 
atmosphere until they reached the desired developmental stage. Chicks 
were staged using HH staging criteria (Hamburger and Hamilton, 1992). 
1 µg/µl DNA + 0.1% fast green was injected multiple times into the hind 
limb buds of HH stage 18–20 chick embryos. For the expression studies,   
-EF1 cDNA was cloned into a pCS3 vector (Rupp et al., 1994). The ECM 
830 ElectroSquarePorator (BTX) was used to generate electric pulses. Two 
gold-plated electrodes ( = 5 mm) were placed dorsally and ventrally of 
the limb bud. Electroporation was performed at the following conditions: 
voltage, 12 V; length of pulse, 50 ms; and frequency, four times.
Quantitative RT-PCR and Western analysis
Limb buds of 12.5–18.5 dpc WT and -EF1
/ embryos were removed 
and  homogenized  for  RNA  extraction.  1  µg  of  each  RNA  sample  was 
transcribed to cDNA. PCR was performed on a Rotor-gene 6000 detec-
tion system (Westburg), and analysis was performed using the accompanied 
software. For Western blot analysis, samples were homogenized in 60 µl 
of NuPage sample buffer (Invitrogen). Protein concentration was measured 
using a BCA Protein Assay Reagent kit (Thermo Fisher Scientific), and 20 µg 
of protein was loaded per lane. Each sample was mixed with 5 µl 0.5M DTT 
and denatured for 5 min at 95°C. For detection of injected -EF1 in chick 
limbs, the samples were loaded on a 8% Tris-glycine (Invitrogen) gel, and 
SDS-PAGE was performed in a Tris-glycine running buffer for 1 h and 30 min 
at 125 V. 200 µg/ml of anti-myc mouse monoclonal antibody (Sanvertech) 
diluted 1:500 in TBS with Tween 20 was used to detect injected -EF1 in 
pCS3. For detection of Ihh and -EF1 in mouse limbs: samples were loaded 
on a 4–12% Bis-Tris gel (Invitrogen), and electrophoresis was performed in 
MES running buffer for 1 h and 30 min at 120 V. Primary anti-IHH and anti-
ZEB antibodies were diluted 1:200. Densitometry analysis of the Western 
blot in Fig. 5 was performed using ImageJ software.
EMSA
DNA fragments of 65 bp containing the putative intron 1 regulatory elements   
of Ihh were obtained using the following DNA oligonucleotides in a PCR reac-
tion using mouse genomic DNA as a template (CACCT/CACCTG sites under-
lined): oligo Ihh EMSA: mIhh EMSA S, 5-CATCGAAGCATCGCCACCTGC-3;   
mIhh EMSA AS, 5-CAGGCAGTCGAGAAAAAAGGTGC-3. To generate   
mutated sites, the following primers were used in PCR reactions as de-
scribed before (mutated base in bold): oligo Ihh EMSA mutant: mIhh 
EMSA  S  mutant,  5-CATCGAAGCATCGCCATCTGC-3;  mIhh  EMSA 
AS mutant, 5-CAGGCAGTCGAGAAAAAAGATGC-3. Nuclear extracts 
were prepared from confluent monolayers of DF1 cells transfected with 
GFP or -EF1 in pCS3 using a standard published method (Tylzanowski 
et al., 2001). 1 µl of nuclear extract was incubated for 40 min at room 
temperature  with  [
32P]ATP  end-labeled  DNA  Ihh  oligo.  Competition 
analysis was performed with 4- or 20-fold molar excess of unlabeled 
Ihh or Ihh mutant DNA fragment. For supershift assays, 1 µl of anti-myc 
mouse  monoclonal  antibody  (200  µg/ml)  was  added  to  the  nuclear   
extract. DNA–protein complexes were separated on a 6% nondenaturing 
in the size of the open reading frame that can be misexpressed, 
namely  2.3  kb.  Because  the  -EF1  open  reading  frame   
is larger than 3 kb, this system cannot be used in our work. 
Currently, there are no alternative expression systems that 
could be used in the chick.
-EF1 haploinsufficiency leads to increased 
trabecular bone mass in adult mice
In this paper, we show that haploinsufficiency of -EF1 in mice 
leads to an increase in the adult bone mass and trabecular bone in a 
gender-independent fashion. Moreover, we detected up-regulation 
of Ihh expression in the growth plates of 8-wk-old -EF1 HZ mice, 
which indicates that the increase in trabecular bone could be the 
result of Ihh derepression. Our hypothesis that -EF1 is a repressor 
of Ihh during postnatal bone growth is supported by several find-
ings. It has been shown that defects in Hh signaling cause a range of 
postnatal mouse phenotypes as well as human disorders affecting 
skeletogenesis (Maeda et al., 2007; Chen et al., 2008; Lodder   
et al., 2008). Moreover, it has been recently reported that Ptc haplo-
insufficiency increased adult bone mass in mice (Ohba et al., 2008). 
Here, the authors have correlated the decrease in Ptc expression to 
ectopic activation of Smo and, therefore, activation of Ihh signaling.   
Additionally, it has also been shown that Ihh produced in postnatal 
chondrocytes is essential to maintain the growth plate and specifi-
cally the trabecular bone (Maeda et al., 2007). Our observation that 
a depletion of -EF1 increases trabecular bone is also in line with 
the studies that both -EF1 and Ihh are expressed in the growth 
plate of the late hypertrophic zone and osteoblasts of 8-wk-old 
mice (Davies et al., 2002), and in early hypertrophic chondrocytes 
and osteoblasts in mouse, rat, and human growth plates (Iwasaki 
et al., 1997; Murakami and Noda, 2000; Kindblom et al., 2002; 
Maeda et al., 2007).
These results suggest that -EF1 is involved in the regula-
tion of multiple steps of skeletal development and postnatal 
homeostasis. We therefore propose that -EF1 acts as a repres-
sor of Ihh transcription involved in the determination of the 
boundaries of Ihh expression and expression levels.
In summary, we demonstrate that -EF1 is a novel in vivo 
regulator of Ihh expression in the growth plate. This finding adds 
to our understanding of growth plate biology and provides new 
insights into bone development and postnatal bone homeostasis.
Materials and methods
Analysis of mouse embryos
-EF1 HZ mice were kindly provided by Y. Higashi (Institute for Develop-
mental  Research,  Aichi  Human  Services  Center,  Osaka,  Japan)  and 
moved into a CD1 background. Mouse colonies were maintained ac-
cording to the National Animal Welfare Guidelines. -EF1
+/ mice in 
CD1 background (backcrossed >10 times) were mated to generate homo-
zygous -EF1
/ embryos. The pregnant mice were sacrificed by cervical 
dislocation. All subsequent mouse work, including skeletal stainings, was 
performed as described previously (Hogan et al., 2004). For analyses   
on sections, embryonic tissues were fixed in 4% paraformaldehyde over-
night at room temperature and embedded in paraffin before sectioning at 
5 µm. Safranin O and von Kossa stainings were performed according to 
standard protocols. Mouse genotyping was performed by PCR on DNA 
isolated from yolk sacs (Hogan et al., 2004). The PCR primers used to 
identify -EF1 WT allele were -EF1 S (5-AGCACTATTCTCCGCTACTC-
CAC-3) and -EF1 AS (5-ACCGCACCTGGTTTACGACACTC-3), gen-
erating a fragment of 193 bp. Primers to identify -EF1 null allele were 697 -EF1 regulates Ihh in the growth plate • Bellon et al.
School of Medicine, Boston, MA) and DF1 cells were a generous gift from 
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polyacrylamide gel in 1× Tris-acetate-EDTA, pH 8.5, at 18 mA. The gel 
was dried and exposed to film (MS; Kodak) for autoradiography.
Reporter assay
WT and mutated 65-bp PCR fragments, as described in the EMSA para-
graph, were cloned into the SmaI site of pGL3tk vector (Promega) im-
mediately upstream of a thymidine kinase minimal promoter (modified 
as described in Verschueren et al., 1999). The cell lines used were C17 
cells, an immortalized cell line from a 13.5-dpc limb bud (provided by 
Vicky Rosen, Harvard University School of Medicine, Boston, MA; Rosen 
et al., 1993), and DF1 cells, a chicken fibroblast cell line (Cheryl Tickle, 
University of Bath, Bath, England, UK; Himly et al., 1998). Cells were co-
transfected with -EF1 expression constructs in pCDNA3 (Remacle et al.,   
1999) using Fugene HD (Roche) method according to manufacturer’s   
instructions. The amount of transfected DNA was adjusted to a total amount 
of 600 ng of DNA with the empty expression vector pCDNA3. Luciferase 
assay was performed 24 h after transfection as described previously   
(Tylzanowski et al., 2001). As an internal control for transfection efficiency, 
cells were cotransfected with RSV-LacZ constructs, and -galactosidase 
values  were  determined  using  a  luminescent  -galactosidase  assay   
(Gal-screen; Tropix).
ChIP
Mouse 16.5-dpc limbs were dissected and frozen at 80°C. Between   
40 and 60 mg of tissue was ground in a mortar with the base submerged in 
liquid nitrogen. Cell lysate was fixed for 10 min in 1% formaldehyde in PBS. 
Chromatin shearing and ChIP assays were performed using the ChIP-IT en-
zymatic kit according to manufacturer’s instructions (Active Motif). Primary 
antibodies were mouse IgG (Biognost) for negative control and anti-ZEB,   
as described in the Immunofluorescence and in situ hybridization section. 
PCR was performed using primers recognizing a 211-bp fragment of the Ihh 
regulatory region: mIhh ChIP S, 5-ATCCCGACATCATCTTCAAGGACG-3;   
mIhh ChIP AS, 5-CCATCTTGGGCAGAAAGACACCC-3.
The primers used to identify the Noggin WT allele were Noggin-S 
(5-GCATGGAGCGCTGCCCCAGC-3) and Noggin-AS (5-GAGCAGC-
GAGCGCAGCAGCG-3), generating a fragment of 200 bp. Primers to   
identify  WT  allele  were  SIP1WT-S  (5-ATCAGCAGCCTCCTATTTAAA-
CAGAGTGTC-3) and SIP1KO-S (5-GAACTAGTTGAATTGGTAGAATCA-
ATGGGG-3), generating a fragment of 150 bp. The PCR conditions were 
annealing at 60°C for 10 s, an extension at 72°C for 20 s, and denaturation 
at 98°C for 3 s.
DEXA and pQCT
Total body (excluding the head) and lumbar spine bone density and lean 
and fat body mass were determined by dual x-ray absorptiometry using a 
Piximus densitometer (Lunar). Trabecular and cortical bone mineral content 
were assessed by pQCT using an XCT Research M system (Norland Medi-
cal Systems). Slices of 0.2 mm in thickness were scanned using a voxel size 
of 0.07 mm. Three scans were taken 2.4–2.6 mm from the distal end of the 
femur or 1.4–1.6 mm from the proximal end of the tibia to determine tra-
becular bone parameters. An additional scan was taken 4 mm from the 
distal end of the femur or 7 mm from the proximal end of the tibia to deter-
mine cortical bone parameters. Statistical analysis was done using a Stu-
dent’s two-sided t test.
Digital image acquisition and analysis
Photography of sections was performed using a SPOT2 digital camera   
(Diagnostic Instruments, Inc.) placed on microscope (DMR; Leica) with the 
following objectives: a 2.5× (0.07 NA) N-Plan objective and 5× (0.15 
NA), 10× (0.30), and 20× (0.50) HC PL Fluotar objectives (all from Leica). 
Skeletal stainings were photographed using a SPOT Insight camera (Diag-
nostic Instruments, Inc.) on a stereo microscope (Discovery V8; Carl Zeiss, 
Inc.) with a 1.0× free working distance 81-mm Plan-S objective or a 0.63× 
FWD 115-mm Achromat-S objective. Images were taken in TIFF format 
with SPOT 4.0.8 software (Diagnostic Instruments, Inc.). Small image modi-
fications (brightness, contrast, and color balance) were performed using 
Photoshop Elements 2.0 (Adobe) on the entire image.
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